Covid-19 treatment: 4 Ayurvedic medicines clear for trial
Ashwagandha, Yashtimadhu, Guduchi +Pippali and a poly herbal formulation (AYUSH-64) cleared for trial in battle against Covid-19
The total number of coronavirus patients in the country rose to 59,662
The government will conduct a randomised controlled clinical trial to assess the efficacy of Ayurvedic drug Ashwagandha as a preventive intervention among healthcare professionals and high-risk coronavirus population in comparison with hydroxychloroquine. This will be a joint initiative of the ministries of AYUSH, health, and science and technology through the Council of Scientific and Industrial Research (CSIR) with technical support from the Indian Council of Medical Research (ICMR).